J.P. Morgan discloses Kangji Medical share dealings

J.P. Morgan Securities PLC, an associate connected with the offeror in the ongoing privatization of Kangji Medical Holdings Limited, has disclosed several dealings in the company's shares. These transactions were made for its own account and are related to the hedging of Delta 1 products from client-driven orders.

Key transactions include a sale of 970,000 shares for a total of $8,567,618.12, with both the highest and lowest prices recorded at $8.83. Another sale involved 1,500 shares totaling $13,308.54, at prices ranging from $8.88 to $8.89.

Additionally, J.P. Morgan Securities PLC executed purchases of Kangji Medical shares. A purchase of 20,500 shares amounted to $182,321.70, with prices between $8.87 and $8.89. A smaller purchase of 1,000 shares was made for $8,865.18, at a consistent price of $8.8652. J.P. Morgan Securities PLC is ultimately owned by JPMorgan Chase & Co.